Seagen, A Wholly Owned Subsidiary Of Pfizer

This study tested a new drug, PF-08046052/SGN-EGFRd2, in people with advanced solid tumors like colorectal, lung, head and neck, and pancreatic cancers. The goal was to find a safe dose and check for side effects. The trial was terminated early, so results are limited. It involve…

This trial tested a drug called tisotumab vedotin, alone or with other medicines, in 214 people with cervical cancer that had come back or spread. The goal was to find the best dose and see if the drug could shrink tumors. The study was stopped early, but the results help guide f…

This study tested a new drug, felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors like ovarian, breast, and lung cancer. The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.

This early-stage study tested a new drug, PF-08046044/SGN-35C, in people with advanced lymphomas (Hodgkin and non-Hodgkin types) who had no other treatment options. The main goal was to check safety and find the right dose. The study was terminated early, so results are limited.

This early-stage study tested a new drug, PF-08046045, in 22 adults with several types of advanced lymphoma (cancers of the immune system). The main goal was to check safety and side effects, and to find the best dose. The study was stopped early, so results are limited.